These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16014395)

  • 21. Intended use of predictive testing by those at risk for Huntington disease.
    Meissen GJ; Berchek RL
    Am J Med Genet; 1987 Feb; 26(2):283-93. PubMed ID: 2949612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Theory of Genetic Vulnerability: a Roy model exemplar.
    Hamilton RJ; Bowers BJ
    Nurs Sci Q; 2007 Jul; 20(3):254-64. PubMed ID: 17595406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic Testing for Huntington's Disease: How Is the Decision Taken?
    Etchegary H
    Genet Test; 2006; 10(1):60-7. PubMed ID: 16545005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disgust in pre-clinical Huntington's disease: a longitudinal study.
    Sprengelmeyer R; Schroeder U; Young AW; Epplen JT
    Neuropsychologia; 2006; 44(4):518-33. PubMed ID: 16098998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of Huntington disease: a model for the stages of psychological response based on experience of a predictive testing program.
    Bloch M; Adam S; Fuller A; Kremer B; Welch JP; Wiggins S; Whyte P; Huggins M; Theilmann J; Hayden MR
    Am J Med Genet; 1993 Sep; 47(3):368-74. PubMed ID: 8135283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding the decision to take the predictive test for Huntington disease.
    Meissen GJ; Mastromauro CA; Kiely DK; McNamara DS; Myers RH
    Am J Med Genet; 1991 Jun; 39(4):404-10. PubMed ID: 1678928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attitudes of German persons at risk for Huntington's disease toward predictive and prenatal testing.
    Kreuz FR
    Genet Couns; 1996; 7(4):303-11. PubMed ID: 8985735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive and pre-natal testing for Huntington Disease in Australia: results and challenges encountered during a 10-year period (1994-2003).
    Tassicker RJ; Marshall PK; Liebeck TA; Keville MA; Singaram BM; Richards FH
    Clin Genet; 2006 Dec; 70(6):480-9. PubMed ID: 17100992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic Counselling for Predictive Testing in Huntington's Disease in One Centre since 1993. Gender-Specific Aspects of Decision-Making.
    Arning L; Witt CN; Epplen JT; Stemmler S
    J Huntingtons Dis; 2015; 4(1):87-98. PubMed ID: 26333260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guidelines for the molecular genetics predictive test in Huntington's disease. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea.
    Neurology; 1994 Aug; 44(8):1533-6. PubMed ID: 8058167
    [No Abstract]   [Full Text] [Related]  

  • 31. Avoidance as a strategy of (not) coping: qualitative interviews with carers of Huntington's Disease patients.
    Lowit A; van Teijlingen ER
    BMC Fam Pract; 2005 Sep; 6():38. PubMed ID: 16162290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychological impact of genetic testing for adult-onset disorders. An update for clinicians.
    Meiser B; Gleeson MA; Tucker KM
    Med J Aust; 2000 Feb; 172(3):126-9. PubMed ID: 10735024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presymptomatic genetic testing in children for neurofibromatosis 2.
    Twomey JG; Bove C; Cassidy D
    J Pediatr Nurs; 2008 Jun; 23(3):183-94. PubMed ID: 18492547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychosocial effects of predictive testing for Huntington's disease.
    Hayden MR; Bombard Y
    Adv Neurol; 2005; 96():226-39. PubMed ID: 16383222
    [No Abstract]   [Full Text] [Related]  

  • 35. Experiments on genetic risk perception and decision making: explorative studies.
    d'Ydewalle G; Evers-Kiebooms G
    Birth Defects Orig Artic Ser; 1987; 23(2):209-25. PubMed ID: 2954593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of Huntington's disease in Slovenia.
    Peterlin B; Kobal J; Teran N; Flisar D; Lovrecić L
    Acta Neurol Scand; 2009 Jun; 119(6):371-5. PubMed ID: 18976322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attachment in families with Huntington's disease. A paradigm in clinical genetics.
    Van der Meer L; Timman R; Trijsburg W; Duisterhof M; Erdman R; Van Elderen T; Tibben A
    Patient Educ Couns; 2006 Oct; 63(1-2):246-54. PubMed ID: 16427763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticipated uptake of genetic testing for familial melanoma in an Australian sample: An exploratory study.
    Kasparian NA; Meiser B; Butow PN; Soames Job RF; Mann GJ
    Psychooncology; 2007 Jan; 16(1):69-78. PubMed ID: 16874747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presymptomatic testing for Huntington's disease by linkage and by direct mutation analysis: comparison of uptake of testing and characteristics of test applicants.
    Holloway SM; Porteous ME; Fitzpatrick DR; Crosbie AE; Cetnarskyj R; Warner J; Barron L
    Genet Couns; 1998; 9(2):103-11. PubMed ID: 9664206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are genetic tests exceptional? Lessons from a qualitative study on thrombophilia.
    Saukko PM; Richards SH; Shepherd MH; Campbell JL
    Soc Sci Med; 2006 Oct; 63(7):1947-59. PubMed ID: 16753245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.